Next Article in Journal / Special Issue
Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy
Previous Article in Journal
Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment
Previous Article in Special Issue
Oncolytic Adenoviruses in Cancer Treatment
Biomedicines 2014, 2(1), 98-109; doi:10.3390/biomedicines2010098

Notes on Article Versions

NoteDate
Article Published5 March 2014 09:06 CET
article pdf uploaded.5 March 2014 09:07 CET
article word file uploaded.5 March 2014 09:07 CET
abstract image uploaded.5 March 2014 09:07 CET
article files uploaded.5 March 2014 09:07 CET
article files uploaded.5 March 2014 09:07 CET
article files uploaded.5 March 2014 09:07 CET
article files uploaded.5 March 2014 09:07 CET
article files uploaded.5 March 2014 09:07 CET
article files uploaded.5 March 2014 09:07 CET
article pdf uploaded.6 March 2014 08:15 CET
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert